Investing.com - NuCana reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
NuCana announced earnings per share of £-0.0019 on revenue of £0.00. Analysts polled by Investing.com anticipated EPS of £-0.0016 on revenue of £0.00.
NuCana shares are down 33.85% from the beginning of the year, still down 62.07% from its 52 week high of £7.83 set on January 13. They are under-performing the Nasdaq which is up 3.19% from the start of the year.
NuCana follows other major Healthcare sector earnings this month
NuCana's report follows an earnings beat by Pfizer on May 4, who reported EPS of £0.93 on revenue of £14.58B, compared to forecasts EPS of £0.7759 on revenue of £13.65B.
AbbVie had beat expectations on April 30 with first quarter EPS of £2.95 on revenue of £13.01B, compared to forecast for EPS of £2.81 on revenue of £12.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar